Reduced TREM2 activation in microglia of patients with Alzheimer's disease

Reduced TREM2 activation in microglia of patients with Alzheimer’s disease

Loss-of-function variants of triggering receptor expressed on myeloid cells 2 (TREM2) enhance the chance of creating Alzheimer’s illness (AD). The mechanism via which TREM2 contributes to the illness (TREM2 activation vs inactivation) is basically unknown. Right here, we analyzed adjustments in a gene set downstream of TREM2 to find out whether or not TREM2 signaling is modified by AD development. We generated […]

Ameliorative effect of myrcene in mouse model of Alzheimer's disease

Ameliorative effect of myrcene in mouse model of Alzheimer’s disease

Myrcene (Myr) has been reported to indicate neuroprotective results in cerebral ischemia. On this analysis work, we investigated the Myr impact on neurobehavioural, and neuropathological alteration in mice induced by Aluminium trichloride (AlCl3) and D – galactose. The administration of AlCl3 (5 mg/kg; p. o.), and D – galactose (60 mg/kg; i. p.) for 90 days […]